Related Experiment Video

Updated: Aug 5, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

Cancer Vaccine Strategies in Non-Small Cell Lung Cancer

Rogelio N Velasco1, Pragadeesh Thamaraiselvan2, Edoardo Garbo3

  • 1Thoracic Oncology Department, Lung Center of the Philippines, Metro Manila 1101, Philippines.

Vaccines
|July 27, 2026
PubMed

Insights

Cancer vaccines show promise for non-small-cell lung cancer (NSCLC) despite current limitations. Ongoing trials explore optimizing vaccine platforms to overcome resistance and improve patient survival.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Immunotherapy has improved lung cancer survival, but resistance remains a significant challenge.
  • Cancer vaccines are an emerging strategy to overcome primary and acquired resistance in non-small-cell lung cancer (NSCLC).
  • Various vaccine platforms are under investigation, including nucleic acid, peptide, dendritic cell, and viral vector-based approaches.

Purpose of the Study:

  • To review the current evidence and challenges of cancer vaccines in treating non-small-cell lung cancer (NSCLC).
  • To summarize the application of different vaccine platforms across various NSCLC stages and therapeutic settings.

Main Methods:

  • Review of current literature and ongoing early-phase clinical trials.
  • Analysis of different cancer vaccine platforms for NSCLC treatment.

Main Results:

  • Cancer vaccines have not yet shown consistent survival benefits in large trials, with limited clinical application.
  • Challenges include high production costs, manufacturing complexity, and issues with drug stability and scalability.
  • Promising signals are emerging from early-phase trials with advancements in neoantigen selection and vaccine optimization.

Conclusions:

  • Cancer vaccines represent a promising avenue for overcoming resistance in NSCLC.
  • Continued research and technological advancements are crucial for optimizing vaccine efficacy, safety, and scalability.
  • Further clinical trials are needed to establish the survival benefit of cancer vaccines in NSCLC treatment.
Keywords:
cancer vaccinesimmunologyimmunotherapylung cancernon-small-cell lung cancervaccines

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...